` LYS (Lysogene SA) vs DAX Index Comparison - Alpha Spread

LYS
vs
D
DAX Index

Over the past 12 months, LYS has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +20% growth.

Stocks Performance
LYS vs DAX Index

Loading
LYS
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
LYS vs DAX Index

Loading
LYS
DAX Index
Difference
www.alphaspread.com

Performance By Year
LYS vs DAX Index

Loading
LYS
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Lysogene SA vs Peers

DAX Index
LYS
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Lysogene SA
Glance View

Market Cap
5m EUR
Industry
Biotechnology

Lysogene SA engages in the research and clinical development of gene therapy for neurodegenerative disorders. The company is headquartered in Neuilly-Sur-Seine, Ile-De-France. The company went IPO on 2017-02-08. The firm is focused on the gene therapy biotechnology. The firm develops treatments targeting severe genetic pathologies with central nervous system involvement and high unmet medical needs. The company is specialized in the development of intracerebral gene therapy aimed at treating pathologies affecting the central nervous system, which is the main cause of neuro-degenerative disease mortality in children.

LYS Intrinsic Value
Not Available
Back to Top